Skip to main content

Table 5 Variables associated with and independent predictors of low adiponectin levels (<6 mg/ml) in 144 NAFLD patients and 257 healthy controls with very low probability of steatosis

From: The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls

Adiponectin

Low (n = 217)

High (n = 194)

p

OR * (95% c.i.)

p *

NAFLD present

89 (46)

52 (24)

0.002

1.65 (1.02-2.70)

0.043

Age (years)

46±11

51±13

0.007

0.96 (0.94-0.98)

<0.0001

Sex (F)

20 (9)

67 (34)

<0.0001

0.21 (0.11-0.37)

<0.0001

BMI (Kg/m2)

26.2±3.0

25.0±3.1

<0.0001

1.15 (1.07-1.25)

0.0002

HDL (mg/dl)

48±12

57±14

<0.0001

-

-

Triglycerides (mg/dl)

119±68

92±47

<0.0001

-

-

ALT (IU/ml)

42±38

29±25

<0.0001

-

-

Insulin (IU/ml)

17±14

13±8

0.003

-

-

FFAs (mmol/l)

0.21±0.09

0.19±0.08

0.05

-

-

ADIPOQ

     

rs2241766TT and rs1501299T+

83 (38)

100 (52)

0.008

0.61 (0.39-0.95)

0.030

rs2241766G + or rs1501299GG

134 (62)

94 (48)

 

reference

 

PNPLA3 rs738409

     

CC (148 I/I)

97 (45)

112 (58)

0.01

1.67° (1.07-2.64)

0.024

CG (148 I/M)

94 (43)

71 (37)

   

GG (148 M/M)

26 (12)

11 (6)

   
  1. ():% values; * OR of low adiponectin at logistic regression analysis considering as independent variables the presence or not of NAFLD, age, gender, BMI, ADIPOQ and PNPLA3 genotype (additive model; OR per number of variant 148 M alleles).